Natural alpha interferon in chronic actinic dermatitis. Report of a case
Parodi, A.; Gallo, R.; Guarrera, M.; Rebora, A.
ActaDermato-Venereologica 75(1): 80
1995
ISSN/ISBN: 0001-5555 PMID: 7747545 Document Number: 450942
Document emailed within 1 workday
Related Documents
Wong, S.N.; Khoo, S.W. 2001: Human immunodeficiency virus infection presenting with chronic actinic dermatitis: a case report Annals of the Academy of Medicine Singapore 30(6): 664-667Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Bolukbas, C.; Bolukbas, F.F.; Kebdir, T.; Canayaz, L.; Dalay, A.R.; Kilic, G.; Ovunc, O. 2005: Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C--a case report and review of the literature Acta Gastro-Enterologica Belgica 68(4): 432-434
Menagé, H.P.; Hawk, J.L. 1999: Chronic actinic dermatitis is not a viable concept Archives of Dermatology 135(4): 469-471
Urabe, A.; Asano, S.; Mizoguchi, H.; Aoki, N.; Takaku, F. 2000: Long-term follow up of chronic myelogenous leukemia patients treated with natural interferon alpha--multi-institutional cooperative study Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(10): 1541-1546
Gustafsson, A.; Sundström, S.; Lundgren, E. 1986: The augmentation of human natural killer cell activity by interferon-gamma is not associated with the induction of the interferon-alpha-inducible proteins Journal of Immunology 137(1): 167-171
Dao, T.; Takeuchi, M.; Fukuda, S.; Kurimoto, M. 1995: Natural human interferon-alpha enhances the expression of intracellular adhesion molecule-1, integrin alpha 2 and beta 1 by a mucosal epithelial cell line Folia Biologica 41(5): 213-225
Musch, E.; Högemann, B.; Gerritzen, A.; Fischer, H.P.; Wiese, M.; Kruis, W.; Malek, M.; Gugler, R.; Schmidt, G.; Huchzermeyer, H.; Gerlach, U.; Dengler, H.J.; Sauerbruch, T. 1998: Phase Ii clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B Hepato-Gastroenterology 45(24): 2282-2294
Radzikowska, E.; Szczepulska-Wójcik, E.; Chabowski, M.; Oniszh, K.; Langfort, R.; Roszkowski, K. 2008: Pulmonary epithelioid haemangioendothelioma--interferon 2-alpha treatment--case report Pneumonologia i Alergologia Polska 76(4): 281-285
Russo, D.; Fanin, R.; Zuffa, E.; Damiani, D.; Gallizia, C.; Michieli, M.; Testoni, N.; Benfenati, D.; Visani, G.; Zaccaria, A. 1990: Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha Haematologica 75(4): 334-339
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Ali, S.; Nazir, G.; Khan, S.A.; Iram, S.; Fatima, F. 2010: Comparative therapeutic response to pegylated interferon plus ribavirin versus interferon alpha-2b in chronic hepatitis C patients Journal of Ayub Medical College Abbottabad: Jamc 22(4): 127-130
Bush, A.E.; Hymes, S.R.; Silapunt, S. 2017: Lichenoid Dermatitis from Interferon alpha-2a in a Patient with Metastatic Renal Cell Carcinoma and Seronegative HCV Journal of Drugs in Dermatology: Jdd 16(7): 714-716
Czarnywojtek, A.; Waligórska-Stachura, J.; Szczepanek, E.; Zgorzalewicz-Stachowiak, M.łg.; Bereszyńska, I.; Kurdybacha, P.; Stangierski, A.; Harasymczuk, J.; Florek, E.; Waśko, R.; Ruchała, M. 2012: A rare case of Interferon-alpha-Induced Hyperthyroidism in patients with a chronic hepatitis C with granulocytopenia and transaminasemia treated successfully with radioiodine Neuro Endocrinology Letters 33(3): 268-272
Hirano, A.; Fujita, T.; Kimura, T.; Katoh, M.; Tsuji, Y.; Kinukawa, T.; Nojiri, Y. 2006: Prolonged complete remission of multiple organ metastases after radical nephrectomy induced by interferon-alpha therapy: a case report Hinyokika Kiyo. Acta Urologica Japonica 52(12): 941-945
Horiguchi, Y.; Ohya, T. 1995: Successful treatment of subacute sclerosing panencephalitis with long-term intrathecal large dose of alpha-interferon--a case report No to Hattatsu 27(3): 231-237
Novick, N.L. 2001: Unilateral, circumscribed, chronic dermatitis of the papillary-areolar complex: case report and review of the literature Mount Sinai Journal of Medicine new York 68(4-5): 321-325
Miller, V.E.; Pohajdak, B.; Greenberg, A.H. 1983: Murine natural antitumor antibodies. III. Interferon treatment of a natural killer-resistant lymphoma: augmentation of natural antibody reactivity and susceptibility to in vivo natural resistance Journal of the National Cancer Institute 71(2): 377-384
Mora, J.S.; Munsat, T.L.; Kao, K.P.; Finison, L.J.; Hedlund, W.; Bradley, G.A.; Scheife, R.; Georgiades, J.A. 1986: Intrathecal administration of natural human interferon alpha in amyotrophic lateral sclerosis Neurology 36(8): 1137-1140
Kishko, I.H. 1999: Peculiarities of production technology and properties of natural animal alpha-interferon preparations Mikrobiolohichnyi Zhurnal 61(2): 57-65